Vornado (VNO) Surges 10.3%: Is This an Indication of Further Gains?

By Zacks Equity Research | April 10, 2025, 10:45 AM

Vornado (VNO) shares rallied 10.3% in the last trading session to close at $35.01. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 12.8% loss over the past four weeks.

The increased investor optimism in the stock can be attributed to President Donald Trump’s recent announcement to put a 90-day pause on the reciprocal tariff for most countries.

This real estate investment trust is expected to post quarterly funds from operations (FFO) of $0.52 per share in its upcoming report, which represents a year-over-year change of -5.5%. Revenues are expected to be $450.05 million, up 3.1% from the year-ago quarter.

While FFO and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in FFO per share estimate revisions and near-term stock price movements.

For Vornado, the consensus FFO per share estimate for the quarter has been revised 0.6% higher over the last 30 days to the current level. And a positive trend in FFO per share estimate revision usually translates into price appreciation. So, make sure to keep an eye on VNO going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Vornado is part of the Zacks REIT and Equity Trust - Other industry. Healthpeak (DOC), another stock in the same industry, closed the last trading session 3.6% higher at $18.64. DOC has returned -11.5% in the past month.

For Healthpeak

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Vornado Realty Trust (VNO): Free Stock Analysis Report
 
Healthpeak Properties, Inc. (DOC): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Mentioned In This Article

Latest News